Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-26T06:33:27.377Z Has data issue: false hasContentIssue false

Salvage Radiosurgery for High Grade Glioma in the Era of Modern Systemic Therapy

Published online by Cambridge University Press:  23 September 2014

Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1. Oh, J, Sahgal, A, Sanghera, P, et al. Glioblastoma: patterns of recurrence and efficacy of salvage treatments. Can J Neurol Sci. 2011 Jul;38(4):6215.CrossRefGoogle Scholar
2. Sherriff, J, Tamangani, J, Senthil, L, et al. Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide. Br J Radiol. 2013 Feb;86(1022):20120414.CrossRefGoogle ScholarPubMed
3. Conti, A, Pontoriero, A, Arpa, D, et al. Efficacy and toxicity of CyberKnife re-irradiation and “dose dense” temozolomide for recurrent gliomas. Acta Neurochir (Wien). 2012 Feb;154(2):2039.CrossRefGoogle ScholarPubMed
4. Elliott, RE, Parker, EC, Rush, SC, et al. Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection. World Neurosurg. 2011 Jul–Aug;76(1–2):12840.CrossRefGoogle ScholarPubMed
5. Shrieve, DC, Alexander, E, 3rd, Wen, PY, et al. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery. 1995 Feb;36(2):27582.Google ScholarPubMed
6. Fields, EC, Damek, D, Gaspar, LE, et al. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):517.CrossRefGoogle ScholarPubMed
7. Chen, C, Damek, D, Gaspar, LE, et al. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):106674.CrossRefGoogle ScholarPubMed
8. Zeiler, FA, Kaufmann, AM, McDonald, PJ, et al. Gamma knife radiosurgery for high grade glial neoplasms: a Canadian experience. Can J Neurol Sci. 2013;40(6):7839.CrossRefGoogle ScholarPubMed
9. Gorlia, T, Stupp, R, Brandes, AA, et al. New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials. Eur J Cancer. 2012 May;48(8):117684.CrossRefGoogle ScholarPubMed
10. Hall, WA, Djalilian, HR, Sperduto, PW, et al. Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol. 1995 Jul;13(7):16428.CrossRefGoogle ScholarPubMed
11. Hsieh, PC, Chandler, JP, Bhangoo, S, et al. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery. 2005 Oct;57(4):68492.CrossRefGoogle ScholarPubMed
12. Hudes, RS, Corn, BW, Werner-Wasik, M, et al. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):2938.CrossRefGoogle ScholarPubMed
13. Larson, DA, Gutin, PH, McDermott, M, et al. Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):104553.CrossRefGoogle ScholarPubMed
14. Patel, M, Siddiqui, F, Jin, JY, et al. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neurooncol. 2009 Apr;92(2):18591.CrossRefGoogle ScholarPubMed
15. Romanelli, P, Conti, A, Pontoriero, A, et al. Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme. Neurosurg Focus. 2009 Dec;27(6):E8.CrossRefGoogle ScholarPubMed
16. Vordermark, D, Kolbl, O, Ruprecht, K, Vince, GH, Bratengeier, K, Flentje, M. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer. 2005;5:55.CrossRefGoogle ScholarPubMed
17. Cuneo, KC, Vredenburgh, JJ, Sampson, JH, et al. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):201824.CrossRefGoogle ScholarPubMed
18. Minniti, G, Armosini, V, Salvati, M, et al. Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma. J Neurooncol. 2011 Jul;103(3):68391.CrossRefGoogle ScholarPubMed
19. Gutin, PH, Wilson, CB. Radiosurgery for malignant brain tumors. J Clin Oncol. 1990 Apr;8(4):5713.CrossRefGoogle ScholarPubMed